MedTrace Logo

PreDM Clinical Decision Support Intervention

NCT04335331 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 7424

Last updated 2023-02-08

No results posted yet for this study

Summary

Clinical practice guidelines recommend intensive lifestyle interventions and metformin to prevent or delay type 2 diabetes; yet these treatments are not routinely used among the 86 million U.S. adults with prediabetes who may benefit from them. While clinical decision support (CDS) represents an effective approach for delivering guideline-based care, the potential of this strategy to improve diabetes prevention efforts has not been definitively tested. This study developed the novel Prevent Diabetes Mellitus Clinical Decision Support (PreDM CDS) intervention and evaluated its impact on clinical outcomes.

Conditions

Sponsors & Collaborators

  • AllianceChicago

    collaborator OTHER

  • Erie Family Health Centers

    collaborator OTHER_GOV

  • Northwestern University

    lead OTHER

Principal Investigators

  • Matthew O'Brien, MD, MSc · Associate Professor

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-02-27
Primary Completion
2021-08-01
Completion
2022-09-02

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04335331 on ClinicalTrials.gov